AncaSt

🧵 1/9 As Nephrology Dialysis Transplantation @NDTsocial celebrates 40 years 🎉, a new editorial ✨ highlights how biological sex shapes CV benefits of exercise in CKD. @VanAmaryllis @olgabalafa @anagarcp #WERA Read the full article at 🔗academic.oup.com/ndt/advance-ar… Read the thread for a sneak peek 👇👇 👇

📣SGLT2 inhibition for patients with ADPKD – closing the evidence gap 👉 an @erakidney e-seminar of the ERA Journal Club Speaker: @MuellerRom Moderator: @willkidney , Parminder Judge Panelist: Roslyn Simms

💁‍♂️12/ Signing off, on behalf of #ERA social media team, Agavriloaei Bogdan @AgavriloaeiB If you’re interested in knowing more about the topic, you can watch the whole seminar e-learning.era-online.org/mod/page/view.…

Gene therapy in inherited kidney disease: are we there yet❓ Gene and RNA therapies aim to fix disease at its genetic cause, not just treat symptoms. For inherited kidney diseases, this raises a new question: are we finally close to real cures? Speaker: @gdorval12 Moderator: Roman-Urlich Müller Panellist: Eris Olinger Panellist: Moin Saleem

Interventional Nephrology: a beginner’s guide for young nephrologists 🧵🧶An ERA - YNP e-seminar 🎙️ @DrBarbaTeba & Marina Urrutia Jou | Moderated by @HDiniz_ 👥 With Jakob Gubensek & Faeq Husain-Syed

1/Worsening renal function and chronic heart failure: double trouble An @erakidney e-seminar of EuReCa-M WG Speaker: @LiffertVogt Moderator: Shanmugakumar Chinnappa Panelist: @VanAmaryllis Panelist: @fiatridi 💊You give furosemide and full dose RAS blockage 👉creatinine rises ⚔️A classic cardio-renal crossover 👇👇Management dilemmas addressed in this seminar

Lupus nephritis: what do new guidelines say? How do the latest international guidelines reshape the diagnosis and management of lupus nephritis (LN)? This e-seminar explores the most recent recommendations from EULAR, KDIGO, and ACR, highlighting key updates, clinical impact, and evidence-based therapeutic strategies to improve patient outcomes. Speaker: Jacob Koopman Speaker: @mxipell Panelist: @smirioglu Moderator/Panelist: Magda Osipyan

/1 Genetics in the Transplant Clinic The collaborative seminar between G&K and DESCaRTEs highlighted the many ways in which genetics 🧬 can play a role in transplantation. Speaker: Jan Halbritter 🇩🇪 Moderator: Emilie Cornec-LeGall 🇫🇷 Panellist: Christophe Mariat 🇫🇷, Maria Vanessa Perez Gomez @perezgomezmv 🇪🇸

Long-term cardiovascular complications following AKI 👉 an @erakidney e-seminar of the EuReCa - M Working group Speaker: @MassyZiad Moderator: Jalanta Malyszko Panelist: @rolyathome Francesca Mallamaci

🚨 Last week to submit your Abstract for #ERA26! ✨ Bring your passion, your vision, and your voice to the world stage Don't miss the chance to challenge your thinking and submit your Abstract by January 28, 2026 👉 bit.ly/4oJx4vp

🧶1/10 Do you treat CKD patients with Obesity? 🚨 Threadorial alert on Nutritional Management of Obesity and CKD. #ERA26 #nephrology An @erakidney e-seminar by Prof. Allon Friedman🇺🇸 Moderator: Prof. Bengt Lindholm🇸🇪 Panellists: Prof. Maria Inês Barreto Silva🇧🇷 & Prof. Carolina Gracia-Iguacel🇪🇸

Stop assuming “Non-Inferior” means “Equal.” 🛑 It is the most dangerous misunderstanding in trials today. 🏎️ Superiority trial (Mercedes) Claim: I am better. Rule: You must beat the standard of care. Reality: If you only tie, you lose. 🚗 Non-Inferiority trial (Toyota Camry) Claim: I am not meaningfully worse, but safer, cheaper, or easier. Rule: You must stay within a predefined margin. Win condition: Similar efficacy with real advantages in safety or QoL. ☠️ The trap everyone misses If a superiority trial fails with p > 0.05, you cannot relabel it as non-inferior. That is not clever statistics. That is incorrect science. ✨A failed superiority trial is just that. A failure. Always read beyond the abstract. #MedTwitter #stats #EBM #MedEd @OncoAlert @ASCO @myESMO @ESMO_Open

Diabetic nephropathy now demands integrative thinking rather than single-pathway solutions. How do RAS modulators and SGLT2 inhibitors converge at a molecular level to deliver renoprotection? And what does that mean for clinical strategy in DKD? - More answers in this e-seminar 👇👇 Speaker: Domenico Cerullo Moderator: @TrilliniMatias Panelists: Milica Bozic and Marieta Theodorakopoulou